Clinical Observation of Addition and Subtraction Therapy of Taohong Siwutang Combined with Chaihu Shugansan to Unstable Angina Pectoris with Type A Behavior Pattern

Li-mei YUAN; Li-hua FAN; Zhi-guo ZHANG; Qing-hai LI

doi:10.13422/j.cnki.syfjx.20191834

您当前的位置：

首页 >

文章列表页 >

Clinical Observation of Addition and Subtraction Therapy of Taohong Siwutang Combined with Chaihu Shugansan to Unstable Angina Pectoris with Type A Behavior Pattern

Clinic | 更新时间：2021-02-09

- Clinical Observation of Addition and Subtraction Therapy of Taohong Siwutang Combined with Chaihu Shugansan to Unstable Angina Pectoris with Type A Behavior Pattern
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 18, Pages: 89-94(2019)
- 作者机构：
  
  1.河南中医药大学，郑州　 450008；
  2.河南中医药大学　第三附属医院，郑州　 450008
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20191834
  CLC： R289; R25; R256; R256.2
- Received：10 April 2019，
  
  Published Online：27 May 2019，
  
  Published：20 September 2019
- 稿件说明：
移动端阅览
Li-mei YUAN, Li-hua FAN, Zhi-guo ZHANG, et al. Clinical Observation of Addition and Subtraction Therapy of Taohong Siwutang Combined with Chaihu Shugansan to Unstable Angina Pectoris with Type A Behavior Pattern[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(18): 89-94.
DOI：

Li-mei YUAN, Li-hua FAN, Zhi-guo ZHANG, et al. Clinical Observation of Addition and Subtraction Therapy of Taohong Siwutang Combined with Chaihu Shugansan to Unstable Angina Pectoris with Type A Behavior Pattern[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(18): 89-94. DOI： 10.13422/j.cnki.syfjx.20191834.

摘要

目的：

观察桃红四物汤合柴胡疏肝散加减治疗不稳定型心绞痛A型行为(气滞血瘀证)的疗效及对促炎因子和5-羟色胺(5-HT)表达的影响。

方法：

将124例患者随机分为对照组60例和观察组64例。对照组口服拜阿司匹林肠溶片，100 mg/次，1次/d；替格瑞洛片，90 mg/次，2次/d；酒石酸美托洛尔片，50 mg/次，2次/d；辛伐他汀片，10 mg/次，1次/d；心绞痛发作时舌下含服硝酸甘油片0.5 mg。观察组西医治疗同对照组，并给予桃红四物汤合柴胡疏肝散加减内服，1剂/d。两组疗程均为连续治疗8周。记录每周心绞痛发作次数、持续时间、疼痛程度和硝酸甘油使用情况；进行治疗前后心电图检测；检测治疗前后甘油三酯(TG)，总胆固醇(TC)，高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C)水平；进行治疗前后西雅图心绞痛量表(SAQ)和气滞血瘀证评分；检测治疗前后白细胞介素-6(IL-6)，肿瘤坏死因子-

(TNF-

)，超敏C反应蛋白(hs-CRP)和5-HT水平。

结果：

经秩和检验；观察组心电图疗效优于对照组(

＝1.965，

0.05)；观察组心绞痛发作次数少于对照组，持续时间缩短于对照组，疼痛程度轻于对照组，硝酸甘油用量少于对照组(

0.01)；观察组SAQ量表各维度评分和SAQ总分均高于对照组(

0.01)；观察组气滞血瘀证各症状评分和总积分均低于对照组(

0.01)；观察组LDL-C低于照组(

0.01)，HDL-C高于对照组(

0.01)；观察组IL-6，hs-CRP，TNF-

和5-HT水平均低于对照组(

0.01)。

结论：

在常规西医治疗的基础上，采用桃红四物汤合柴胡疏肝散加减治疗不稳定型心绞痛(UAP)A型行为(气滞血瘀证)患者，可进一步控制心绞痛发作情况，减轻临床症状，提高生活质量，调节脂代谢，并可抑制促炎因子和5-HT表达，起到稳定病情的作用。

Abstract

Objective:

To observe the clinical efficacy of addition and subtraction therapy of Taohong Siwutang combined with Chaihu Shugansan to unstable angina pectoris with type A behavior pattern (Qi stagnation and blood stasis syndrome)

and investigate its effects on proinflammatory factors and serotonin (5-HT).

Method:

One hundred twenty-four patients were randomly divided into control group (60 cases) and observation group(64 cases) by random number table. Patients in control group got Aspirin enteric-coated tablets

100 mg/time

1 time/day. Tigrillo tablets

90 mg/time

2 times/days. Metoprolol tartrate tablets

50 mg/time

2 times/days. Simvastatin tablets

10 mg/time

1 time/day. Nitroglycerin tablets

0.5 mg/time. Based on the treatment in control group

patients in observation group also received addition and subtraction therapy of Taohong Siwutang combined with Chaihu Shugansan

1 dose/day. The treatment course was 8 weeks in both groups. Number of attacks

duration

degree of pain and usage of nitroglycerin were recorded for every week. Before and after treatment

electrocardiogram was also recorded. And levels of triglyceride (TG)

total cholesterol (TC)

high density lipoprotein cholesterol (HDL-C)

low density lipoprotein cholesterol (LDL-C)

interleukin-6 (IL-6)

tumor necrosis factor-

(TNF-

)

hypersensitive C-reactive protein and 5-HT were detected. In addition

scores of Seattle Angina Scale (SAQ) and Qi stagnation and blood stasis syndrome were graded.

Result:

In the rank sum test

the curative effect in electrocardiogram of observation group was better than that of control group (

=1.965

0.05). Number of attacks

duration

degree of pain and usage of nitroglycerin were all less than those in control group (

0.01). Scores of various dimensions in SAQ and the total scores of SAQ were all higher than those in control group (

0.01). Scores of various symptoms for Qi stagnation and blood stasis syndrome and the total scores were lower than those in control group (

0.01). Levels of LDL-C

IL-6

hs-CRP

TNF-

and 5-HT in observation group were lower than those in control group (

0.01)

while level of HDL-C was higher than that in control group (

0.01).

Conclusion:

On the basis of conventional western medicine

addition and subtraction therapy of Taohong Siwutang combined with Chaihu Shugansan can further control angina attack

relieve clinical symptoms

improve quality of life

regulate lipid metabolism

and can inhibit expression of proinflammatory factors and 5-HT

so it can play a role in stabilizing the disease.

关键词

Keywords

references

崔静，牛春霞，汪涵，等．柔肝化瘀法治疗不稳定型心绞痛A型行为患者的理论探讨 [J]．中国中西医结合杂志， 2018 ， 38 ( 9 )： 1123 - 1126 ．

滕树恩，黄铮，谢晋国，等．不稳定型心绞痛患者择期PCI术后替格瑞洛抗血小板治疗晚期临床疗效及安全性评价 [J]．中国动脉硬化杂志， 2016 ， 24 ( 6 )： 591 - 594 ．

靳文学，何德英，乔秀兰．冠心颗粒对稳定性心绞痛炎症反应的影响 [J]．中国实验方剂学杂志， 2017 ， 23 ( 12 )： 182 - 187 ．

周臻，司晓晨． A型行为与冠心病相关研究进展 [J]．中西医结合心脑血管病杂志， 2014 ， 12 ( 2 )： 236 - 238 ．

牛春霞，汪涵，崔静，等．中医药对A型行为UAP患者炎性因子影响的研究进展 [J]．医学综述， 2015 ， 21 ( 22 )： 4059 - 4061 ．

肖阳，张艳，孙铭鸿．中医药治疗不稳定型心绞痛研究进展 [J]．辽宁中医药大学学报， 2017 ， 19 ( 2 )： 222 - 224 ．

魏红玲，张明雪．从肝论治胸痹的证机浅析 [J]．中医药信息， 2016 ， 33 ( 3 )： 60 - 62 ．

路娟，王敏，王朋朋．桃红四物汤对冠心病心绞痛患者血清超敏C反应蛋白及血液流变学的影响 [J]．海南医学， 2018 ， 29 ( 22 )： 3129 - 3131 ．

黄小燕，刘中勇．从肝论治冠心病心绞痛 [J]．江西中医药大学学报， 2014 ， 26 ( 1 )： 19 - 22 ．

中华医学会心血管病学分会，中华心血管病杂志编辑委员会．不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南 [J]．中华心血管病杂志， 2007 ， 35 ( 4 )： 295 - 305 ．

中华中医药学会．中医内科常见病诊疗指南(西医疾病部分) [M]．北京：中国中医药科技出版社， 2008 ： 47 - 50 ．

李静，常改．西雅图量表测量冠心病患者生活质量的评价 [J]．中国公共卫生， 2004 ， 20 ( 5 )： 594 - 596 ．

何美娟．中医对冠心病A型行为的认识 [J]．中西医结合心血管病电子杂志， 2017 ， 5 ( 30 )： 14 - 15 ．

吴楠． “双心医学”在A型性格冠心病合并焦虑抑郁障碍患者中的应用 [J]．甘肃医药， 2018 ， 37 ( 7 )： 593 - 595 ．

周小芳，程晓昱．程晓昱治疗冠心病稳定型心绞痛临证经验 [J]．江西中医药大学学报， 2018 ， 30 ( 5 )： 26 - 28 ．

冒慧敏，刘秀华，史大卓．桃红四物汤治疗冠心病的机制研究进展 [J]．环球中医药， 2016 ， 9 ( 9 )： 1145 - 1148 ．

倪新强，曹美群，吴正治，等．柴胡疏肝散的化学成分和药理作用研究进展 [J]．上海中医药杂志， 2017 ， 51 ( 9 )： 109 - 113 ．

王阶，姚魁武，刘咏梅，等．冠心病血瘀证转录组学研究——病证结合生物标准物研究思路与方法 [J]．中国实验方剂学杂志， 2017 ， 23 ( 19 )： 1 - 5 ．

刘亮，胡有志．柴胡疏肝散加减联用比索洛尔治疗双心病人40例 [J]．中西医结合心脑血管病杂志， 2014 ， 12 ( 1 )： 5 - 6 ．

龚初平．血浆儿茶酚胺，5-羟色胺检测在A型行为冠心病患者的临床意义分析 [J]．中国当代医药， 2016 ， 23 ( 23 )： 126 - 128 ．

王阶，滕菲，刘咏梅，等．血塞通对冠心病不稳定型心绞痛血瘀证患者microRNA的干预作用 [J]．中国实验方剂学杂志， 2017 ， 23 ( 19 )： 11 - 16 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Randomized Double-blind Placebo-controlled Study on Clinical Efficacy and Mechanism of Shexiang Baoxinwan in Treating Stable Angina Pectoris Complicated with Anxiety and Depression in Coronary Artery Disease

Comprehensive Clinical Evaluation of Xiaojie'an Capsules in Treatment of Uterine Fibroids with Qi Stagnation and Blood Stasis Syndrome

Protective Effect of Taohong Siwutang on Cerebral Ischemia-reperfusion Injury Based on A1/A2 Phenotype Transformation of Astrocytes Mediated by JAK2/STAT3 Pathway

Clinical Observation on Chaihu Shugansan Combined with Xuanfu Daizhetang in Treating Barrett's Esophagus with Liver-stomach Disharmony

Taohong Siwutang Exerts Anti-inflammatory Effect and Regulates Caspase-14 and EVPL Expression in Treatment of Psoriasis

Related Author

WANG Jie

LONG Linzi

ZHAO Zhiru

LIAO Feifei

LU Jieming

LIU Tianjiao

PENG Yuxuan

QU Hua

Related Institution

Graduate School，Beijing University of Chinese Medicine

Xiyuan Hospital， China Academy of Chinese Medical Sciences

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences

MOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials

Anhui Province Key Laboratory of Chinese Medicinal Formula

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰